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Background: Pancreatic fistula is still one of the most serious and potential complications after D2-D3 distal and
total gastrectomy (4% to 6%). Despite their importance, pancreatic fistulas still have not been uniformly defined.
Amylase concentration of the drainage fluid after surgery for gastric cancer can be considered as a predictive factor
of the presence of pancreatic fistula.
Methods: From January 2009 to April 2013, 53 patients underwent surgery for gastric cancer. Amylase
concentration in the drainage fluid was measured on the first postoperative day and if it was ≥1,000 UI, it was
measured again on the third postoperative day. Pancreatic fistula occurred in four cases (7.5%). Pancreatic fistulas
were classified using the International Study Group on Pancreatic Fistula (ISGPF) criteria into different grades of
severity. Two fistulas were Grade A, one was Grade B, and one was Grade C.
Results: Management of drainage tubes is still crucial after gastrectomy, not only for the likelihood of anastomotic
leaks but also the eventual diagnosis and management of pancreatic fistula. High amylase drainage content and
then the presence of the pancreatic fistula may be due to several causes: the operation itself when it includes
splenectomy or pancreatic tail-splenectomy, the extended lymphadenectomy but even the ‘gently and softly’
pancreatic manipulation, according literature, may be a risk factor.
Conclusions: The authors assessed amylase concentration in the drainage fluid collected from the left subphrenic
cavity on POD1 and POD3 in 53 patients who had undergone curative gastrectomy for cancer and concluded that
amylase drainage content >3 times the serum amylase was a useful predictive risk factor for pancreatic fistula. Our
work is an interim analysis and the aim of this study is to increase the accrual of the number of patients to have a
significant number. For this reason, a protocol for a multicenter trial will be designed to verify whether the
systematic measurement of amylase in drain fluid is better than abdominal ultrasound for the detection of
pancreatic fistula after gastric cancer surgery.
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Pancreatic fistula is still one of the most serious poten-
tial complications after D2-D3 distal and total gastrec-
tomy (4% to 6%) [1-4].
Systematic lymphadenectomy, splenectomy, and distal
pancreasectomy during the surgical procedure for gastric
cancer appear to be responsible for several complica-
tions: abdominal abscess, anastomotic leakage, wound
abscess, lymphorrhea, anastomotic stenosis, postopera-
tive bleeding, cardiac failure, bowel obstruction and
pancreas-related complications such as pancreatic leak-
age and fistula [2,5] (Table 1).
The insertion of drainage tubes can be useful for the
prediction and management of these complications. Des-
pite their importance, pancreatic fistulas still have not
been uniformly defined.
Amylase concentration of the drainage fluid after sur-
gery for gastric cancer can be considered a useful predict-
ive risk factor for pancreatic-related complications [4-6].
In 2005 the International Study Group on Pancreatic
Fistula (ISGPF) developed a universal definition for pan-
creatic fistula: drain output of any measurable volume of
fluid on or after postoperative day 3 with an amylase
content >3 times the serum amylase activity [4].
We measured amylase drain fluid concentration and
also the volume produced; and we considered this valid
only for drain fluid production higher than 400 cc [1].
Many authors consider amylase concentration ≥1,000
UI on the first postoperative day as a significant risk fac-
tor for pancreatic fistula.
In this paper we want to demonstrate if amylase con-
centration in drainage fluid on the first day after sur-
gery for gastric cancer can be considered a useful and
potential risk factor for pancreatic-related complica-
tions, especially for pancreatic fistula [4,5]. Our study is
an interim analysis and the aim of this paper is to in-
crease the number of patients in order to have a signifi-
cant number.Table 1 Incidence of postoperative complications after
gastric surgery
Postoperative complication Incidence (%)
Wound abscess 7.3
Pneumonia 6







From January 2009 to April 2013, 53 patients under-
went surgery for gastric cancer at the Department of
General Surgery, Terni Saint Mary Hospital, University
of Perugia.
There were 28 men and 25 women, and the mean age
of patients was 72.3 years (age range, 42 to 88 years), the
patients had given consents.
D2 distal gastrectomy was performed in 30 cases, the
remaining 23 had undergone D2 total gastrectomy, in-
cluding nine cases with splenectomy and one case with
pancreatic tail-splenectomy.
The histologic types were: three patients were T1b and
three patients were T2, while 27 patients were T3 and 20
patients were T4.
Two drainage tubes connected to a bag for drainage
fluid collection were placed in the left subphrenic cavity
and Winslow’s cavity in the patient who had undergone
total gastrectomy and only one in the left subphrenic
cavity in patients treated with D2 distal gastrectomy.
Amylase concentration in the drainage fluid was mea-
sured on the first postoperative day and if it was ≥1,000
UI, it was measured again on the third postoperative
day. Drainage fluid was sampled from the left subphre-
nic cavity in all the cases on days 1[5] and 3. We also
sampled serum amylase and lipase concentration and
tube drainage fluid volume in all of the patients [6].
We removed the drainage tube on postoperative day 7,
after radiological control, if the drain amylase concentra-
tion was three times lower than serum amylase concen-
tration. We did not remove the drain tube in patients
that had drainage amylase value three times higher than
serum amylase. (Ethics Committee approval was not re-
quired in these cases, because placement of the drainage
tubes connected to a bag for drainage fluid collection is
common clinical practice).
We define pancreatic fistula when the amylase in drain
production is >1,000 IU/L, independent of the volume
produced (Tables 2 and 3).
Results
Postoperative pancreatic fistula occurred in four cases
(7.5%) (Table 4). These pancreatic fistulas were classified
using ISGPF criteria [4] in different grades of severity
(Table 5). Using the ISGPF classification [4], patients in
our study with drainage amylase on or after the the third
postoperative day three times higher than the normalTable 2 Characteristics of the 53 patients enrolled in our
study
Mean age (years) 72.3 (range, 42–88)
M:F ratio 28:25
TNM T1-2: 6 patients, T3-4: 47 patients
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were Grade A, one was Grade B, and one was Grade C.
The Grade A patients did not undergo any treatment
but they required a longer hospitalization (7 to 10 days
longer than normal).
The Grade B patient underwent total parenteral nutri-
tion and somatostatine and then antibiotic treatment
(piperacilline + tazobactam 4.5 mg three times a day).
The Grade C patient underwent a second operation
for acute pancreatitis, pancreatic abscess, and occlusion
for adynamic ileum. This patient underwent abscess
drainage and ileostomy. The patient died on the 10th
postoperative day due to multiorgan failure.
For patients with a fistula of Grade B or higher, a se-
verity classification of Clavien-Dindo [4] was used
(Table 6). Of our four patients with postoperative pan-
creatic fistula one of them was Clavien-Dindo Grade I,
two were Grade IIIa, and one Grade IIIb. The first one
(Grade I) was treated only pharmacologically, the other
three (IIIa and IIIb) underwent invasive procedures.
Among the patients that developed pancreatic fistula,
one underwent total gastrectomy and D2 lymphadenec-
tomy and the other three underwent distal gastrectomy
and D2 lymphadenectomy. Two of them were T3, oneTable 4 Description of patients with pancreatic fistula
Sex Age (years) Exams Surgery
M 72 • Endoscopy TG
• CT scan D2 lymphadenect
• Endoscopic US
F 81 • Endoscopy DG
• CT scan D2 lymphadenect
• Endoscopic US
M 65 • Endoscopy DG
• CT scan D2 lymphadenect
• Endoscopic US
M 78 • Endoscopy DG
• CT scan D2 lymphadenect
• Endoscopic USwas T2, and the last one was T1b. Only one T3 patient
was N3. According to Lauren histological classification,
three were intestinal histotype and one was diffuse histo-
type. All of them were adenocarcinomas.
No development of pancreatic fistula was observed
with less than three times increased amylase during the
first 3 postoperative days and absence of pancreatic fis-
tula with more than three times increased amylase dur-
ing the first 3 postoperative days.Discussion
Management of drainage tubes is still very important
after gastrectomy [3], not only for the possible anasto-
motic leaks but also for the prediction and management
of pancreatic fistula.
In fact many studies have demonstrated that qualita-
tive analysis of the drainage content is very important to
predict and manage this complication after gastric sur-
gery for cancer.
In our discussion, it is important to underline that dif-
ferential diagnosis between lymphorrhea and pancreatic
fistula has been performed measuring triglycerides in
drainage fluid.
Many authors [6] consider some parameters:
– drainage amylase concentration
– lipase drainage concentration
– drainage volume.
In our experience, and in accordance with many stud-
ies [6], we prefer to consider amylase drainage concen-
tration [5] overall because it has demonstrated that
lipase concentration is related to amylase concentration
and drainage volume is not significant. It also demon-
strated that drainage volume is often elevated in patientsHistology Clevien-Dindo
Adenocarcinoma of gastric remnant
omy T3 N3 MX R0 Grade IIIa
G3
omy T3 N0 MX R0 Grade I
G2
omy T1b N0 MX R0 Grade IIIb
G1
Grade IIIa
omy T2 N0 MX
G2-G3
Table 5 ISGPF classification for pancreatic fistula
No fistula Drainage amylase on or after postoperative day 3 is not
three times than upper normal serum amylase value
Grade A No specific treatment was required even though
drainage amylase on or after postoperative day 3 is
three times than upper normal serum amylase value
Grade B Requires a change management or adjustment of
clinical pathway (antibiotics, total parenteral nutrition,
or repositioning of drainage tubes)
Grade C Requires major charge in the clinical pathway; clinical
intervention is aggressive and often in the ICU setting
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extended lymphadenectomy [2,6].
Examination of drainage fluid in these patients was nor-
mal so we can suppose it was only lymphorrhea [6,7].
High amylase drainage content followed by pancreatic
fistula risk may be due to many causes: the operation it-
self, when it includes splenectomy or pancreatic tail-
splenectomy; the extended lymphadenectomy; and even
the ‘gently and softly’ pancreatic manipulation.
In conclusion, we affirm that patients who had under-
gone total gastrectomy with splenectomy and extended
lymphadenectomy (D2-D3) had more frequently an
amylase content >3 times than the serum amylase con-
centration on the first and third postoperative days [4].Table 6 Clavien-Dindo classification
Grades Definition
Grade I Any deviation from the normal postoperative course
without the need for pharmacological treatment or
surgical, endoscopic, and radiological interventions
Allowed therapeutic regimens are: drugs as antiemetics,
antipyretics, analgetics, diuretics and electrolytes, and
physiotherapy. This grade also includes wound
infections opened at the bedside
Grade II Requiring pharmacological treatment with drugs other
than such allowed for Grade I complications. Blood
transfusions and total parenteral nutrition are
also included
Grade III Requiring surgical, endoscopic, or radiological
intervention
Grade IIIa Intervention not under general anesthesia
Grade IIIb Intervention under general anesthesia
Grade IV Life-threatening complication (including CNS
complications: brain hemorrhage, ischemic stroke,
subarachnoid bleeding, but excluding transient
ischemic attacks) requiring IC/ICU management
Grade IVa Single organ dysfunction (including dialysis)
Grade IVb: Multi-organ dysfunction
Grade V Death of the patient
Suffix ‘d’ If the patient suffers from a complication at the
time of discharge, the suffix ‘d’ (for ‘disability’) is
added to the respective grade of complication. This
label indicates the need for a follow-up to fully
evaluate the complicationIn fact we can consider the followings as risk factors
for pancreatic fistula after surgery for gastric cancer:
– pancreatic manipulation (even gently and softly)
– surgery (pancreatic tail resection, extended
lymphadenectomy).
In our experience we noticed that the amylase drain-
age level was related to the duration of the fistula. Our
preliminary data are similar to those in international lit-
erature [1,5,8-10] (Table 7).Conclusion
Despite its importance, pancreatic fistulas have still
not been uniformly defined. Only a few studies have
attempted to correlate the concentration of amylase in
drain fluid with the risk of developing complications.
Pancreatic fistula is still one of the most serious com-
plications after D2-D3 gastrectomy for gastric cancer. It
is natural that pancreatic fistula is frequent if drain
amylase is high. The absolute value of drain amylase has
no significance since the value may be changed by ascitic
concentrations.
Pancreatic fistula developed in four of our patients
and amylase concentration of the drainage fluid seemed
to be a useful indicator for this complication in patients
with lymphorrhea resulting in D2 gastrectomy. Ascites
from lymphadenectomy does not reduce the sensitivity
of amylase concentration of the drainage.
In this interim analysis the number of the patients
with D2 gastrectomy (53 patients) is too small to reach a
definitive conclusion. The future aim of this work is to
increase the accrual of the number of patients to have a
significant number.
For this reason, a protocol for a multicenter trial will
been designed to verify whether the systematic measure-
ment of amylase in drain fluid is better than abdominal
ultrasound for the detection of pancreatic fistula after
gastric cancer surgery.Table 7 Pancreatic fistula incidence: review of literature
Study Surgical treatment Pancreatic fistula
incidence (%)
Iwata el al. [5] D1-D2 gastrectomy 16.3
Tomimaru et al. [8] D1-D2 gastrectomy 9.2
Sano et al. [9] D1-D2 gastrectomy 13.7
Kodera et al. [10] D2-D3 gastrectomy 5.7
Sano et al. [1] D2 gastrectomy 5.3
Sasako et al. [11] Distal and Total gastrectomy 6.0
Furukawa et al. [12] D2 gastrectomy 13
Nobouka et al. [13] D2 gastrectomy 18
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